Standard THC units as a unit of measurement: differences & complementarity with other THC metrics [0.03%]
标准四氢大麻酚单位作为测量单位：与其他四氢大麻酚指标的差异及互补性
Valentina Lorenzetti,Dave Hammond,Shea Wood et al.
Valentina Lorenzetti et al.
Changing trends in safer opioid supply uptake, dose and hydromorphone volume in Ontario: A population-based cross-sectional study [0.03%]
安大略省基于人群的横断面研究中阿片类药物安全供应接受情况、剂量和氢可酮用量的变化趋势
Felix Xu,Tianru Wang,Gillian Kolla et al.
Felix Xu et al.
Introduction: Safer opioid supply involves prescribed pharmaceutical opioids as alternatives to unregulated drug supply for people at high-risk of opioid toxicity. In Canada, this is primarily achieved through prescribing...
Alcohol Retail Lobbying: A comparative analysis of profit and not-for-profit alcohol retail peak body written submissions to Australian parliamentary inquiries [0.03%]
澳大利亚酒精零售业游说行为的比较分析——基于澳大利亚议会调查听证会上行业团体书面意见书的考察研究
Claire Wilkinson,Michala Kowalski
Claire Wilkinson
Aims: The alcohol, tobacco and gambling industries are notorious for lobbying against increased taxation and public-health focused regulations. These actions are often attributed to the commercial structure of these indus...
A decentralized point of service triple prevention and treatment model for hepatitis B, C and HIV in people who inject drugs in South Africa [0.03%]
南非安 injector人群乙肝、丙肝和艾滋病去中心化防治服务模式研究
Elaine Saayman,Vanessa B Hechter,Nozipho S Sishwili et al.
Elaine Saayman et al.
Background: The burden of viral hepatitis and HIV in sub-Saharan Africa is substantial with an estimated 64.7 million living with hepatitis B virus (HBV), 8 million with hepatitis C virus (HCV) and 20.8 million people liv...
Factors influencing the acceptability of hepatitis C screening among people with experience of incarceration in Quebec, Canada: A qualitative descriptive study guided by the Theoretical Domains Framework [0.03%]
加拿大魁北克省具有监禁经历的人群接受丙型肝炎筛查的因素：一项由行为理论领域框架指导的定性描述研究
Andrea Mambro,Guillaume Fontaine,David Ortiz-Paredes et al.
Andrea Mambro et al.
Background: For hepatitis C virus (HCV) elimination to occur in carceral settings, opt-out screening on admission, the first step in the HCV care cascade, is recommended. As screening strategies in Quebec provincial priso...
"It makes all the sense in the world": A qualitative evaluation of patient perspectives on implementation outcomes of a peer-facilitated integrated infectious disease and substance use care model [0.03%]
“这在世界上说得通”：一种同龄人促进的综合传染病和物质使用护理模型实施结果的患者视角质性评估
Annice Brown,Sharon M Kelly,Tracy Agee et al.
Annice Brown et al.
Background: Integration of substance use disorder (SUD) care into infectious disease care settings has potential to address high rates of SUD among people with infectious diseases. An understanding of patient perspectives...
Sharing drug checking results in a Canadian setting: a multi-site analysis [0.03%]
加拿大环境下分享药物检查结果的多点位分析
Joshua Bird,Samuel Tobias,Cameron Grant et al.
Joshua Bird et al.
Background: Drug checking services (DCS) have been implemented as a harm reduction measure to address high rates of illicit drug morbidity and mortality. In addition to reducing individual-level risk, there is also potent...
Is drug-use stigma a breach of human rights law?: Insights from Australia [0.03%]
毒品用药污名是侵犯人权吗？——来自澳大利亚的启示
Sean Mulcahy,Kate Seear,Carla Treloar
Sean Mulcahy
Whilst international drug policy increasingly recognises the need to address drug-use stigma, there is limited consideration of how drug-use stigma can be addressed through legal frameworks. This commentary considers the relationship betwee...
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study [0.03%]
直接抗病毒治疗成功后的丙型肝炎病毒感染再感染：SHARP-C 研究
Joshua Ang,Behzad Hajarizadeh,Shane Tillakeratne et al.
Joshua Ang et al.
Background: Injecting drug use following treatment for hepatitis C virus (HCV) may result in reinfection, potentially reversing individual, and population benefits of HCV treatment. The aim of this study was to evaluate t...